Literature DB >> 18076993

Dengue virus infection induces passive release of high mobility group box 1 protein by epithelial cells.

Lien-Cheng Chen1, Trai-Ming Yeh, Huey-Nan Wu, Yi-Ying Lin, Huey-Wen Shyu.   

Abstract

OBJECTIVES: Dengue hemorrhagic fever and dengue shock syndrome (DHF/DSS) are severe complications of secondary dengue virus (DV) infection. In the current study, we provide the first evidence of induction of cellular necrosis by DV type 2 (DV-2). METHODS AND
RESULTS: The epithelial cell line A549 can support replication of dengue virus as demonstrated by expression of viral NS1 antigen and virus plaque assay. DV-2 infection of cells induced cell death in approximately half of the cells that were actively infected. Using sodium 3'-[1-(phenylaminocarbonyl)-3, 4-tetrazolium]-bis(4-methoxy-6-nitro) benzene sulfonic acid hydrate [XTT]-based cell viability assays, we found that DV-2 infection at a multiplicity of infection (MOI) of 10 resulted in significant death of cells as well as high extracellular lactate dehydrogenase (LDH) activity and leakage of the high mobility group 1 (HMGB1) protein into the extracellular space.
CONCLUSIONS: These results suggest that HMGB1 may be a signal of tissue or cellular injury by DV-2, which in turn is likely to induce and/or enhance an immune reaction.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18076993     DOI: 10.1016/j.jinf.2007.10.008

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  24 in total

1.  Hepatitis C virus infection is blocked by HMGB1 released from virus-infected cells.

Authors:  Jong Ha Jung; Ji Hoon Park; Min Hyeok Jee; Sun Ju Keum; Min-Sun Cho; Seung Kew Yoon; Sung Key Jang
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

Review 2.  Targeting HMGB1 in the treatment of sepsis.

Authors:  Haichao Wang; Mary F Ward; Andrew E Sama
Journal:  Expert Opin Ther Targets       Date:  2014-01-06       Impact factor: 6.902

3.  Retinoic acid inducible gene-I and melanoma differentiation-associated gene 5 are induced but not essential for dengue virus induced type I interferon response.

Authors:  Cheng-Feng Qin; Hui Zhao; Zhong-Yu Liu; Tao Jiang; Yong-Qiang Deng; Xu-Dong Yu; Man Yu; E-De Qin
Journal:  Mol Biol Rep       Date:  2010-11-27       Impact factor: 2.316

Review 4.  High mobility group box 1 protein as a potential drug target for infection- and injury-elicited inflammation.

Authors:  Shu Zhu; Wei Li; Mary F Ward; Andrew E Sama; Haichao Wang
Journal:  Inflamm Allergy Drug Targets       Date:  2010-03

Review 5.  Molecular mechanism and therapeutic modulation of high mobility group box 1 release and action: an updated review.

Authors:  Ben Lu; Ce Wang; Mao Wang; Wei Li; Fangping Chen; Kevin J Tracey; Haichao Wang
Journal:  Expert Rev Clin Immunol       Date:  2014-04-19       Impact factor: 4.473

6.  High mobility group box 1 protein as an auxiliary biomarker for dengue diagnosis.

Authors:  Diego Allonso; Susana Vázquez; Maria G Guzmán; Ronaldo Mohana-Borges
Journal:  Am J Trop Med Hyg       Date:  2012-12-26       Impact factor: 2.345

Review 7.  Novel HMGB1-inhibiting therapeutic agents for experimental sepsis.

Authors:  Haichao Wang; Mary F Ward; Andrew E Sama
Journal:  Shock       Date:  2009-10       Impact factor: 3.454

8.  Using Complementary and Alternative Medicines to Target the Host Response during Severe Influenza.

Authors:  Lisa M Alleva; Charles Cai; Ian A Clark
Journal:  Evid Based Complement Alternat Med       Date:  2009-09-24       Impact factor: 2.629

9.  Dengue virus infection mediates HMGB1 release from monocytes involving PCAF acetylase complex and induces vascular leakage in endothelial cells.

Authors:  Siew Pei Ong; Ling Min Lee; Yew Fai Ivan Leong; Mah Lee Ng; Justin Jang Hann Chu
Journal:  PLoS One       Date:  2012-07-30       Impact factor: 3.240

10.  Dengue virus enhances thrombomodulin and ICAM-1 expression through the macrophage migration inhibitory factor induction of the MAPK and PI3K signaling pathways.

Authors:  Trai-Ming Yeh; Shu-Hsiang Liu; Kao-Chang Lin; Chieh Kuo; Shu-Yun Kuo; Tzuu-Yuan Huang; Yong-Ren Yen; Rong-Kun Wen; Lien-Cheng Chen; Tsai-Feng Fu
Journal:  PLoS One       Date:  2013-01-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.